New York, NY – Mandy Moore takes center stage by signing the PetArmor Pledge to fight for better pet health on Wednesday, April 20th 2011. Moore know for her recent successful film “Tangle” has turned her focus towards to animal rights and welfare issues that concern all pet owners.
Moore will be among the first to take the pledge and has encouraged everyone to do the same. This year’s event is designed to raise awareness for better pet healthcare for all pets. The Pet Pledge is sponsored by PetArmor, which will donate $1 (up to $100,000) to ASPCA for each individual that signs up on Facebook and takes the PetArmor pledge. PetArmor is the first EPA- approved generic flea and tick treatment for both dogs and cats.
The ASPCA also has a Pledge to Fight Animal Cruelty
- Yes – I support the ASPCA in its steadfast commitment to end animal cruelty. I will do all that is possible to help the animals in my community live happy, healthy lives.
- Learn to recognize Animal Cruelty
- Report Animal Cruelty
- Set a Good Example for others
- Fight for the Passage of Anti-Cruelty laws by Joining the ASPCA Advocacy Brigade.
Over the past several years there has been a documented history connecting animal abuse to domestic violence. A study in New Jersey found that 88 percent of families where physical abuse to children was present also showed abuse to animals as well. The National Coalition Against Domestic Violence also supported this trend by reporting that 85.4 percent of women and 63.0 percent of children report pet abuse after arriving at domestic violence shelters.
According to the Chicago Police Department there is legitimate evidence to suggest that those individuals that commit violent acts against animals present a danger to the public.
So what can you do? The ASPCA recommends that you document any signs of animal abuse and report them immediately animal rights and welfare authorities that can investigate animal cruelty.
To learn more about Mandy Moore visit www.mandymoore.com.
[…] Mandy Moore Crusades For Pet Health […]
Comments are closed.